510(k) Report

510(k) · Cleared

Cleared

Sitzmarks

K181750510(k) TraditionalCleared Nov 15, 2018136-day reviewClass II21 CFR 876.1725

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Konsyl Pharmaceuticals · FFX System, Gastrointestinal Motility (Electrical)

Cleared on Nov 15, 2018 after a 136-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 2 later devices descend from it.

Decided
Nov 15, 2018
Review
136 days
Class
Class II
Product code
FFX
Recalls
None
Predicates
0

2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2019: 1 descendant cleared2020: 1 descendant cleared201620182020202220242026
  1. This deviceK181750 SitzmarksKonsyl Pharmaceuticals · 2018
  2. Descendant · cites it directly · 1 of its ownK191087 IntraMarX Radiopaque MarkersAnx Robotica Corp · 2019
  3. Descendant · 2 generations on · 0 of its ownK201106 IntraMarX 3D Radiopaque MarkerAnx Robotica Corp · 2020

Most influential descendants

Showing 2 of 2 · See all
  • K191087IntraMarX Radiopaque MarkersAnx Robotica Corp · 2019 · cites it directly1descendant
  • K201106IntraMarX 3D Radiopaque MarkerAnx Robotica Corp · 2020 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K181750SitzmarksKonsyl Pharmaceuticals2018—
+1K191087IntraMarX Radiopaque MarkersAnx Robotica Corp2019—
+2K201106IntraMarX 3D Radiopaque MarkerAnx Robotica Corp2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201910
202010
FIG. 1 — Lineage of K181750, 2018–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FFX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FFX device

  1. #1 K262621 Rapid Barostat Bag (RBB) Pump and Catheter…score 12.4 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K191087IntraMarX Radiopaque MarkersAnx Robotica Corp20191

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K191087 (Anx Robotica Corp, 2019) has gone furthest, with 1 descendant of its own.

How does its category compare?

All FFX devices

FFX System, Gastrointestinal Motility (Electrical): FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · FFX

1in 2025

2007: 22008: 12009: 22010: 22012: 42013: 12016: 32017: 22018: 12019: 42020: 12023: 32024: 12025: 12026 (partial year): 1
2007high 4 (2012) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FFX

123in 2023

2012: 120 days median2016: 145 days median2019: 240 days median2023: 123 days median
2007high 240 (2019) · low 120 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FFX

2so far in 2026, the most since 2007

2009: 12011: 12026 (partial year): 2
2007high 2 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FFX

32in 2025

2009: 22010: 62011: 62012: 42013: 42014: 42015: 102016: 152017: 102018: 172019: 272020: 202021: 262022: 312023: 512024: 592025: 32
2007high 59 (2024) · low 0 (2007)2025

MAUDE reports naming product code FFX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—00
20092—12
20102—06
20110—16
2012412004
20131—04
20140—04
20150—010
20163145015
20172—010
20181—017
20194240027
20201—020
20210—026
20220—031
20233123051
20241—059
20251—032
20261—2—

What is it indicated for?

SITZMARKS capsule is a diagnostic test indicated for aiding in the evaluation of colonic motility in patients with severe constipation, as diagnosed by your healthcare professional, but otherwise negative GI evaluations. SITZMARKS capsule, for use in adult and pediatric patients (at least 2 years old), is to be dispensed only by physicians to patients for oral intake.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K181750: Sitzmarks.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K181750

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026